How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?

Journal of Artificial Organs

Volumn 15, Issue 4, 2012, Pages 395-398

  Imamura, Teruhiko ^a   Kinugawa, Koichiro ^a   Shiga, Taro ^a   Kato, Naoko ^a   Endo, Miyoko ^a   Inaba, Toshiro ^a   Maki, Hisataka ^a   Hatano, Masaru ^a   Yao, Atsushi ^a   Hirata, Yasunobu ^a   Akahane, Masaaki ^a   Nishimura, Takashi ^a   Kyo, Shunei ^a   Ono, Minoru ^a   Nagai, Ryozo ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Continuous flow; Implantable; Organ failure; VAD

Indexed keywords

BILIRUBIN; CANDESARTAN; CARVEDILOL; CREATININE; DOBUTAMINE; EPLERENONE; FUROSEMIDE; LOSARTAN; PIMOBENDAN;

ADULT; AORTA PRESSURE; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIAC RESYNCHRONIZATION THERAPY; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; DYSPNEA; FATIGUE; HEART CATHETERIZATION; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART RIGHT ATRIUM PRESSURE; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAAORTIC BALLOON PUMP; INVASIVE PROCEDURE; LEFT VENTRICULAR ASSIST DEVICE; LIVER BIOPSY; MALE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE;

ADULT; CARDIOMYOPATHY, DILATED; EQUIPMENT DESIGN; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HEPATITIS; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; ORGAN DYSFUNCTION SCORES; PATIENT SELECTION; RENAL INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84876208577     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-012-0654-4     Document Type: Article

References (22)

1. Steinman TI, Becker BN, Frost AE, Olthoff KM, Smart FW, Suki WN, Wilkinson AH. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation. 2001;71:1189-204.
2. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: international Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant. 2006;25:1024-42.
3. Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL 2nd, Kobashigawa J. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation. 2004;110:3858-65.
4. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, Kirk R, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-eighth Adult Heart Transplant Report - 2011. J Heart Lung Transplant. 2011;30:1078-94.
5. Khot UN, Mishra M, Yamani MH, Smedira NG, Paganini E, Yeager M, Buda T, McCarthy PM, Young JB, Starling RC. Severe renal dysfunction complicating cardiogenic shock is not a contraindication to mechanical support as a bridge to cardiac transplantation. J Am Coll Cardiol. 2003;41:381-5.
6. Bank AJ, Mir SH, Nguyen DQ, Bolman RM 3rd, Shumway SJ, Miller LW, Kaiser DR, Ormaza SM, Park SJ. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg. 2000;69:1369-74 (discussion 75).
7. Reinhartz O, Farrar DJ, Hershon JH, Avery GJ Jr, Haeusslein EA, Hill JD. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg. 1998;116:633-40.
8. Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation. 2009;120:2352-7.
9. Kinugawa K. How to treat stage D heart failure? When to implant left ventricular assist devices in the era of continuous flow pumps? Circ J. 2011;75:2038-45.
10. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31:117-26.
11. Saito S, Matsumiya G, Sakaguchi T, Fujita T, Kuratani T, Ichikawa H, Sawa Y. Fifteen-year experience with Toyobo paracorporeal left ventricular assist system. J Artif Organs. 2009;12:27-34.
12. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Ulisney KL, Baldwin JT, Young JB. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30:115-23.
13. Bonis PA, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N Engl J Med. 2001;344:452-4.
14. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
15. Kalambokis G, Manousou P, Vibhakorn S, Marelli L, Cholongitas E, Senzolo M, Patch D, Burroughs AK. Transjugular liver biopsy - indications, adequacy, quality of specimens, and complications - a systematic review. J Hepatol. 2007;47:284-94.
16. Gelow JM, Desai AS, Hochberg CP, Glickman JN, Givertz MM, Fang JC. Clinical predictors of hepatic fibrosis in chronic advanced heart failure. Circ Heart Fail. 2010;3:59-64.
17. Clinical competence in percutaneous renal biopsy. Health and Public Policy Committee. American College of Physicians. Ann Intern Med. 1988;108:301-3.
18. Abbott KC, Musio FM, Chung EM, Lomis NN, Lane JD, Yuan CM. Transjugular renal biopsy in high-risk patients: an American case series. BMC Nephrol. 2002;11:5.
19. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens. 2004;13:661-5.
20. Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart-failure - relationship of cardiac index to kidney-function. Drugs. 1990;39:10-21.
21. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN 3rd. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741-7.
22. Perazella MA, Coca SG, Kanbay M, Brewster UC, Parikh CR. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol. 2008;3:1615-9.